Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1993 2
1995 2
1996 1
1997 1
1998 1
1999 1
2000 2
2001 3
2002 1
2004 1
2005 2
2006 2
2007 1
2009 2
2010 1
2011 1
2012 3
2013 4
2014 1
2015 2
2016 4
2017 7
2018 10
2019 7
2020 5
2021 6
2022 7
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Retinitis pigmentosa 37"
Page 1
Molecular Epidemiology in 591 Italian Probands With Nonsyndromic Retinitis Pigmentosa and Usher Syndrome.
Colombo L, Maltese PE, Castori M, El Shamieh S, Zeitz C, Audo I, Zulian A, Marinelli C, Benedetti S, Costantini A, Bressan S, Percio M, Ferri P, Abeshi A, Bertelli M, Rossetti L. Colombo L, et al. Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):13. doi: 10.1167/iovs.62.2.13. Invest Ophthalmol Vis Sci. 2021. PMID: 33576794 Free PMC article.
PURPOSE: To describe the molecular epidemiology of nonsyndromic retinitis pigmentosa (RP) and Usher syndrome (US) in Italian patients. ...
PURPOSE: To describe the molecular epidemiology of nonsyndromic retinitis pigmentosa (RP) and Usher syndrome (US) in Italian p …
Progression Rate of Visual Function and Affecting Factors at Different Stages of Retinitis Pigmentosa.
Ito N, Miura G, Shiko Y, Kawasaki Y, Baba T, Yamamoto S. Ito N, et al. Biomed Res Int. 2022 Jul 14;2022:7204954. doi: 10.1155/2022/7204954. eCollection 2022. Biomed Res Int. 2022. PMID: 35872870 Free PMC article. Review.
We reviewed medical records of 121 patients/235 eyes of typical retinitis pigmentosa (RP) patients who could be followed up for at least 5 years with the aim of investigating the long-term course of visual function progression at each RP stage and appropriate …
We reviewed medical records of 121 patients/235 eyes of typical retinitis pigmentosa (RP) patients who could be followed up fo …
Visual Field Progression in Retinitis Pigmentosa.
Xu M, Zhai Y, MacDonald IM. Xu M, et al. Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):56. doi: 10.1167/iovs.61.6.56. Invest Ophthalmol Vis Sci. 2020. PMID: 32589198 Free PMC article.
PURPOSE: To retrospectively study the rate of visual field (VF) progression in patients with retinitis pigmentosa (RP) as it relates to different targets and inheritance patterns. ...
PURPOSE: To retrospectively study the rate of visual field (VF) progression in patients with retinitis pigmentosa (RP) as it r …
Spectral Domain optical coherence tomography findings in patients with retinitis pigmentosa.
Chebil A, Touati S, Maamouri R, Kort F, El Matri L. Chebil A, et al. Tunis Med. 2016 Apr;94(4):265-271. Tunis Med. 2016. PMID: 27704509
Background Maculopathy is a common complication of retinitis pigmentosa (RP), and compromise the visual acuity of RP patients even in the less advanced stages. Aim To report the morphological macular findings detected by spectral domain optical coherence tomography …
Background Maculopathy is a common complication of retinitis pigmentosa (RP), and compromise the visual acuity of RP patients …
Prevalence of cystoid macular oedema, epiretinal membrane and cataract in retinitis pigmentosa.
Liew G, Strong S, Bradley P, Severn P, Moore AT, Webster AR, Mitchell P, Kifley A, Michaelides M. Liew G, et al. Br J Ophthalmol. 2019 Aug;103(8):1163-1166. doi: 10.1136/bjophthalmol-2018-311964. Epub 2018 Oct 5. Br J Ophthalmol. 2019. PMID: 30291136
BACKGROUND/AIMS: To report the prevalence of treatable complications (cystoid macular oedema, CME; epiretinal membrane, ERM and cataract) in patients with retinitis pigmentosa (RP). METHODS: Consecutive patients with RP attending a tertiary eye clinic in 2012. ...
BACKGROUND/AIMS: To report the prevalence of treatable complications (cystoid macular oedema, CME; epiretinal membrane, ERM and cataract) in …
Coats-like Vasculopathy in Inherited Retinal Disease: Prevalence, Characteristics, Genetics, and Management.
Daich Varela M, Conti GM, Malka S, Vaclavik V, Mahroo OA, Webster AR, Tran V, Michaelides M. Daich Varela M, et al. Ophthalmology. 2023 Dec;130(12):1327-1335. doi: 10.1016/j.ophtha.2023.07.027. Epub 2023 Aug 5. Ophthalmology. 2023. PMID: 37544434 Free PMC article.
RESULTS: The prevalence of IRD-related CLV was 0.5%; 54% of patients had isolated retinitis pigmentosa (RP), 21% had early-onset severe retinal dystrophy, and less frequent presentations were syndromic RP, sector RP, cone-rod dystrophy, achromatopsia, PAX6-related d …
RESULTS: The prevalence of IRD-related CLV was 0.5%; 54% of patients had isolated retinitis pigmentosa (RP), 21% had early-ons …
Frequency of cystoid macular edema and vitreomacular interface disorders in genetically solved syndromic and non-syndromic retinitis pigmentosa.
Marques JP, Neves E, Geada S, Carvalho AL, Murta J, Saraiva J, Silva R. Marques JP, et al. Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2859-2866. doi: 10.1007/s00417-022-05649-y. Epub 2022 Apr 7. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35389060

PURPOSE: Retinitis pigmentosa (RP) corresponds to a group of inherited retinal disorders where progressive rod-cone degeneration is observed. ...Mixed-effects univariate linear regression identified age (p = 0.04), cataract surgery (p < 0.01), and loss of integri

…
PURPOSE: Retinitis pigmentosa (RP) corresponds to a group of inherited retinal disorders where progressive rod-cone degenerati …
INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA.
Mansour AM, Sheheitli H, Kucukerdonmez C, Sisk RA, Moura R, Moschos MM, Lima LH, Al-Shaar L, Arevalo JF, Maia M, Foster RE, Kayikcioglu O, Kozak I, Kurup S, Zegarra H, Gallego-Pinazo R, Hamam RN, Bejjani RA, Cinar E, Erakgün ET, Kimura A, Teixeira A. Mansour AM, et al. Retina. 2018 Feb;38(2):416-423. doi: 10.1097/IAE.0000000000001542. Retina. 2018. PMID: 28221257 Clinical Trial.
PURPOSE: To report the clinical outcome after intravitreal dexamethasone implant in patients with retinitis pigmentosa and cystoid macular edema. METHODS: Multicenter retrospective case series of eyes with retinitis pigmentosa and cystoid macular edema …
PURPOSE: To report the clinical outcome after intravitreal dexamethasone implant in patients with retinitis pigmentosa and cys …
Management of Retinitis Pigmentosa via Platelet-Rich Plasma or Combination with Electromagnetic Stimulation: Retrospective Analysis of 1-Year Results.
Arslan U, Özmert E. Arslan U, et al. Adv Ther. 2020 May;37(5):2390-2412. doi: 10.1007/s12325-020-01308-y. Epub 2020 Apr 18. Adv Ther. 2020. PMID: 32303913
PURPOSE: To investigate whether the natural progression rate of retinitis pigmentosa can be decreased by subtenon autologous platelet-rich plasma application alone or combination with retinal electromagnetic stimulation. METHODS: The study includes retrospective ana …
PURPOSE: To investigate whether the natural progression rate of retinitis pigmentosa can be decreased by subtenon autologous p …
Time Course of Disease Progression of PRPF31-mediated Retinitis Pigmentosa.
Kiser K, Webb-Jones KD, Bowne SJ, Sullivan LS, Daiger SP, Birch DG. Kiser K, et al. Am J Ophthalmol. 2019 Apr;200:76-84. doi: 10.1016/j.ajo.2018.12.009. Epub 2018 Dec 21. Am J Ophthalmol. 2019. PMID: 30582903 Free PMC article.
PURPOSE: Variants in PRPF31, a splicing factor, are a common cause of autosomal dominant retinitis pigmentosa (RP). Deleterious variants are thought to cause disease by haploinsufficiency. ...In those with RP, visual field area (spot size III) declined exponentially …
PURPOSE: Variants in PRPF31, a splicing factor, are a common cause of autosomal dominant retinitis pigmentosa (RP). Deleteriou …
75 results